Daniel Shapiro
@d_shapiro1
Followers
843
Following
3K
Media
56
Statuses
1K
Urologic oncologist @wiscurology | Former fellow @MDAndersonNews | Former resident @wiscurology
Madison, WI
Joined April 2011
RT @urotoday: Vigorous physical activity as a potential environmental risk factor in renal medullary carcinoma. Patients reporting intense….
0
2
0
Don’t miss the @KidneyCancer patient symposium on Sept 6! Our virtual tumor board will dive into treatment decision-making in kidney cancer. I really enjoyed participating and learning from the experts. @UWCarbone @wiscurology
0
9
23
RT @triadsou: Fair Coins Tend to Land on the Same Side They Started: Evidence from 350,757 Flips. Bartoš F et al. Journal of the American S….
tandfonline.com
Many people have flipped coins but few have stopped to ponder the statistical and physical intricacies of the process. We collected 350,757 coin flips to test the counterintuitive prediction from a...
0
4
0
Thank you @GEVaughan1 you are too kind! I have been so happy to be involved in such a great organization as the KCA. @KidneyCancer.
Happy Birthday, @d_shapiro1! You translate confusing science to a way we all understand. Always responsive, always kind, always funny. The KCA loves you!
0
0
12
RT @ChadTangMD: Amazing work led by Alex Sherry! @piet_ost @ebludmir @OncHahn @MDAndersonNews @VedangMurthy @drdavidpalma @d_shapiro1 @_Sha….
0
13
0
RT @ebludmir: @ChadTangMD & I happy to report: ph2 basket EXTEND-OP trial has enrolled and randomized 150 patients in the last year since o….
0
12
0
RT @PavlosMsaouel: 1/5 How reproducible are phase III oncology trials?.📊 With @AlexSherryMD @ErikVanZwet @ebludmir et al. We analyzed 632 R….
0
36
0
Check out our latest work on RMC!.
1/5 #RenalMedullaryCarcinoma (RMC) is a lethal #KidneyCancer in young people with #SickleCellTrait (SCT). Our new prospective study @UrolOncol asks: does VIGOROUS exercise raise risk? 👉#MsaouelLab
1
5
24
RT @PavlosMsaouel: 🚀 Now enrolling @MDAndersonNews: IVORY trial of #ivonescimab (first-in-class PD1×VEGF bispecific) in metastatic clear ce….
0
29
0
RT @PavlosMsaouel: First trial of PD1/VEGF bispecific in #kidneycancer just activated today and is @NazliDizman’s trial design project duri….
0
11
0
RT @SStevenWang: 2025 Nature Index: Harvard has dropped to No. 2 after the Chinese Academy of Sciences. No. 1 and 3-9 are all Chinese resea….
0
101
0
RT @PavlosMsaouel: 1/5 This comes up in #kidneycancer clinic every few months. And on patient groups just as often. 📊 The ASSURE nomogram s….
0
24
0
RT @KidneyCancer: 🏃♂️ Can individuals with sickle cell trait exercise? Yes, with knowledge and care!. Exercise is essential for overall he….
0
4
0
RT @KidneyCancer: 🚨 Sickle cell trait + intense workouts = could be dangerous if you're not prepared. Here's what athletes need to know ➡️….
0
3
0
RT @Aiims1742: PIVOT is a very useful open source tool from @AshleyKiemen @andreforjaz @deniswirtz and colleagues at @hopkinskimmel that al….
0
21
0
RT @KidneyCancer: Today is #WorldSickleCellDay. Carriers of the sickle cell trait are at increased risk for a rare & aggressive #kidneycanc….
0
2
0
RT @nataliagandur: 🌟🎓👏🧵 RCC Highlights @ #ASCO25 | Part 1.💬 Brilliant discussion by @TiansterZhang on 4 pivotal studies in advanced ccRCC.@….
0
20
0
RT @_backtableONC: In Ep. 13, @ejasonabel, Dr. Louis Hinshaw, and @RuchikaTalwarMD explain how urologists and radiologists work together to….
0
4
0
RT @UrologyTimes: Daniel D. Shapiro, MD, FACS, (@d_shapiro1) and E. Jason Abel, MD, FACS, (@ejasonabel) discuss optimal patient selection f….
urologytimes.com
"Appropriate patient selection for CN is a highly individualized process that is improved with a multidisciplinary approach," write the authors.
0
4
0
RT @PavlosMsaouel: Appreciate @signmagazine making the primer on randomized non-comparative trials (RNCTs) freely available help to raise a….
academic.oup.com
Abstract. A regular series exploring slip-ups, snafus and salutary lessons from the world of statistics.
0
13
0